Matches in SemOpenAlex for { <https://semopenalex.org/work/W3202823770> ?p ?o ?g. }
- W3202823770 endingPage "56" @default.
- W3202823770 startingPage "43" @default.
- W3202823770 abstract "Membrane vesicles, including exosomes and microparticles (MPs), serve to package and transfer the cellular cargo during inter/extracellular communication, which is of great interest in cancer development, especially in the dissemination of signal transduction-associated traits from donor cells to recipient cells. Although increasing evidence suggests that microparticles (MPs) contribute to the development of cancer, their unique characteristics remain to be exploited. Here, we examined the secretion of MPs in tumor tissues from triple-negative breast cancer (TNBC) patients and found that the tumor cells could release MPs loaded with immune checkpoint molecular programmed cell death ligand 1 (PD-L1), especially in patients treated with traditional clinical interventions, such as chemotherapy and radiotherapy. These PD-L1-loading MPs contribute to the suppressive immune microenvironment, eventually resulting in the tumor progression in TNBC. Mechanically, we proved that PD-L1-loading MPs could suppress the activation and function of functional cluster of differentiation CD8+ T cells. Meanwhile, the PD-L1-loading MPs could mediate the differentiation of macrophages toward the immune-suppressive M2 phenotype via the activation of the TANK-binding kinase 1 (TBK1)/signal transducer and activator of transcription 6 (STAT6) signal and suppression of the serine-threonine kinase (AKT)/mammalian target of rapamycin (mTOR) signal. Given the increasing MP production induced by traditional clinical interventions, we further combined chemotherapy with the PD-L1 inhibitor atezolizumab (ATZ) to efficiently abrogate the immunosuppression caused by the PD-L1-loading MPs. Therefore, our study unveils the mechanism by which tumor cells systemically evade immune surveillance by releasing the PD-L1-loading MPs, and provides new insights into clinical TNBC immunotherapy." @default.
- W3202823770 created "2021-10-11" @default.
- W3202823770 creator A5000385663 @default.
- W3202823770 creator A5008098651 @default.
- W3202823770 creator A5009590736 @default.
- W3202823770 creator A5027535273 @default.
- W3202823770 creator A5028701240 @default.
- W3202823770 creator A5051824135 @default.
- W3202823770 creator A5059723671 @default.
- W3202823770 creator A5070054348 @default.
- W3202823770 date "2021-12-01" @default.
- W3202823770 modified "2023-10-18" @default.
- W3202823770 title "Tumor-derived microparticles promote the progression of triple-negative breast cancer via PD-L1-associated immune suppression" @default.
- W3202823770 cites W1256125786 @default.
- W3202823770 cites W1488814076 @default.
- W3202823770 cites W1655528082 @default.
- W3202823770 cites W1918028620 @default.
- W3202823770 cites W1980236054 @default.
- W3202823770 cites W1986328483 @default.
- W3202823770 cites W2028376975 @default.
- W3202823770 cites W2058648826 @default.
- W3202823770 cites W2087993142 @default.
- W3202823770 cites W2100927341 @default.
- W3202823770 cites W2108933323 @default.
- W3202823770 cites W2120338564 @default.
- W3202823770 cites W2136166312 @default.
- W3202823770 cites W2310715021 @default.
- W3202823770 cites W2313168486 @default.
- W3202823770 cites W2323793261 @default.
- W3202823770 cites W2560836545 @default.
- W3202823770 cites W2567639438 @default.
- W3202823770 cites W2595182131 @default.
- W3202823770 cites W2613186675 @default.
- W3202823770 cites W2725777854 @default.
- W3202823770 cites W2739170155 @default.
- W3202823770 cites W2773236705 @default.
- W3202823770 cites W2783897381 @default.
- W3202823770 cites W2785643516 @default.
- W3202823770 cites W2801501414 @default.
- W3202823770 cites W2818713708 @default.
- W3202823770 cites W2883594834 @default.
- W3202823770 cites W2887249435 @default.
- W3202823770 cites W2889110748 @default.
- W3202823770 cites W2890156321 @default.
- W3202823770 cites W2901140226 @default.
- W3202823770 cites W2911909558 @default.
- W3202823770 cites W2914311347 @default.
- W3202823770 cites W2915321625 @default.
- W3202823770 cites W2934922729 @default.
- W3202823770 cites W2953295279 @default.
- W3202823770 cites W2981768007 @default.
- W3202823770 cites W2984150354 @default.
- W3202823770 cites W2986865303 @default.
- W3202823770 cites W2988353924 @default.
- W3202823770 cites W3010122169 @default.
- W3202823770 cites W3137310994 @default.
- W3202823770 cites W4214728613 @default.
- W3202823770 cites W4255548056 @default.
- W3202823770 cites W4255724971 @default.
- W3202823770 doi "https://doi.org/10.1016/j.canlet.2021.09.039" @default.
- W3202823770 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34601021" @default.
- W3202823770 hasPublicationYear "2021" @default.
- W3202823770 type Work @default.
- W3202823770 sameAs 3202823770 @default.
- W3202823770 citedByCount "19" @default.
- W3202823770 countsByYear W32028237702022 @default.
- W3202823770 countsByYear W32028237702023 @default.
- W3202823770 crossrefType "journal-article" @default.
- W3202823770 hasAuthorship W3202823770A5000385663 @default.
- W3202823770 hasAuthorship W3202823770A5008098651 @default.
- W3202823770 hasAuthorship W3202823770A5009590736 @default.
- W3202823770 hasAuthorship W3202823770A5027535273 @default.
- W3202823770 hasAuthorship W3202823770A5028701240 @default.
- W3202823770 hasAuthorship W3202823770A5051824135 @default.
- W3202823770 hasAuthorship W3202823770A5059723671 @default.
- W3202823770 hasAuthorship W3202823770A5070054348 @default.
- W3202823770 hasConcept C104317684 @default.
- W3202823770 hasConcept C121608353 @default.
- W3202823770 hasConcept C126322002 @default.
- W3202823770 hasConcept C145059251 @default.
- W3202823770 hasConcept C203014093 @default.
- W3202823770 hasConcept C20518536 @default.
- W3202823770 hasConcept C2776107976 @default.
- W3202823770 hasConcept C2779256057 @default.
- W3202823770 hasConcept C2780110267 @default.
- W3202823770 hasConcept C502942594 @default.
- W3202823770 hasConcept C530470458 @default.
- W3202823770 hasConcept C55493867 @default.
- W3202823770 hasConcept C62478195 @default.
- W3202823770 hasConcept C71924100 @default.
- W3202823770 hasConcept C75217442 @default.
- W3202823770 hasConcept C86554907 @default.
- W3202823770 hasConcept C86803240 @default.
- W3202823770 hasConcept C8891405 @default.
- W3202823770 hasConcept C95444343 @default.
- W3202823770 hasConceptScore W3202823770C104317684 @default.
- W3202823770 hasConceptScore W3202823770C121608353 @default.
- W3202823770 hasConceptScore W3202823770C126322002 @default.